Price
Frequently asked questions
What is Neogen's market capitalization?
What is the Earnings Per Share (EPS) for Neogen?
What are the analyst ratings and target price for Neogen's stock?
What is Neogen's revenue over the trailing twelve months?
What is the EBITDA for Neogen?
What is the free cash flow of Neogen?
What is the 5-year beta of Neogen's stock?
How many employees does Neogen have, and what sector and industry does it belong to?
What is the free float of Neogen's shares?
Financials
Market Cap
$3.55B5Y beta
1.25EPS (TTM)
-$0.109Free Float
216.13MRevenue (TTM)
$912.20MEBITDA (TTM)
$192.64MFree Cashflow (TTM)
-$124.88MPricing
Analyst Ratings
The price target is $17.00 and the stock is covered by 2 analysts.
Buy
1
Hold
1
Sell
0
Information
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
2,917
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker